Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Momentum
Price
Volume
Vol 1d %
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
RSI
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D
MACD
MACD Signal
MACD Histogram
Beta
HURA
TUHURA BIOSCIENCES INC
$2.46105,00034.62%2.793.043.583.534.4929.3010.3815.4920.1932.29-0.28-0.24-0.040.77
NVCT
NUVECTIS PHARMA INC
$8.41122,00083.46%8.859.409.288.467.3638.2212.2516.762.377.51-0.20-0.10-0.100.31
GLMD
GALMED PHARMACEUTICALS LTD
$1.60301,00072.00%1.561.461.411.852.8658.2682.9887.7575.2485.260.060.030.030.79
ENTA
ENANTA PHARMACEUTICALS INC
$7.50244,000-12.23%7.326.615.786.087.8365.9170.2980.0764.4482.000.540.430.100.93
EDIT
EDITAS MEDICINE INC
$1.973,051,000-4.80%1.931.791.541.522.0958.5071.3377.2161.3680.830.150.120.022.03
MLYS
MINERALYS THERAPEUTICS INC
$14.32589,000-18.76%15.6215.7314.6613.2212.8639.5317.3635.860.0011.750.090.30-0.211.01
PGEN
PRECIGEN INC
$1.521,254,00052.93%1.441.411.411.541.2357.6971.7973.1183.4988.060.020.000.021.70
AMLX
AMYLYX PHARMACEUTICALS INC
$5.52890,000-14.51%5.325.234.734.144.1159.1658.8067.9558.2367.590.210.190.021.18
TCRX
TSCAN THERAPEUTICS INC
$1.55195,000-22.92%1.671.521.441.713.1350.5347.6259.0315.6635.300.060.060.000.70
IMMP
IMMUTEP LTD
$1.7447,000-80.17%1.821.891.771.831.9742.5113.5419.0014.8326.94-0.020.01-0.020.93
RNAZ
TRANSCODE THERAPEUTICS INC
$6.9740,3007.47%7.257.229.3770.40197.2136.5242.9947.5374.4785.84-1.47-2.000.541.31
XENE
XENON PHARMACEUTICALS INC
$32.76612,000-42.21%31.5130.7132.8335.0637.8955.8486.3885.7099.6499.29-0.19-0.690.500.83
TRDA
ENTRADA THERAPEUTICS INC
$7.59118,00053.25%8.057.938.219.9813.5241.1030.5245.8842.9863.57-0.15-0.160.011.06
JAGX
JAGUAR HEALTH INC
$3.4970,00037.25%3.904.386.3510.9218.9429.976.167.1217.1322.13-0.97-1.030.061.28
LYRA
LYRA THERAPEUTICS INC
$11.34220,000-40.54%19.0911.967.838.4510.0348.9924.9929.9023.2328.502.502.99-0.480.56
MAIA
MAIA BIOTECHNOLOGY INC
$1.7259,600-61.55%1.781.781.811.792.1444.308.8215.6910.9121.55-0.02-0.02-0.010.43
AKRO
AKERO THERAPEUTICS INC
$55.622,224,00041.39%53.4949.6143.7545.0837.0069.4275.4375.2570.0075.303.222.890.330.55
IMNN
IMUNON INC
$1.431,576,0006.92%1.661.411.070.990.9751.1934.8939.3923.5640.330.170.21-0.040.90
HUMA
HUMACYTE INC
$2.372,722,000-14.72%2.562.521.872.663.8752.0426.6443.090.007.010.160.21-0.051.42
CGON
CG ONCOLOGY INC
$25.86626,000-10.57%26.6526.1723.8125.6730.0050.3743.3055.897.1438.180.530.63-0.101.56
GANX
GAIN THERAPEUTICS INC
$1.73221,0002.79%1.891.861.852.021.9640.4316.3426.035.8621.32-0.02-0.01-0.011.07
IDYA
IDEAYA BIOSCIENCES INC
$22.18863,000-38.00%21.7520.4318.8119.6224.5964.1879.3382.4064.1575.511.000.840.161.07
QTTB
Q32 BIO INC
$1.67155,000170.03%1.801.771.742.1116.7144.8324.7930.2810.1916.25-0.010.01-0.011.12
OKUR
ONKURE THERAPEUTICS INC
$2.65165,000315.62%2.822.552.593.887.0050.0464.5573.9559.4876.850.080.030.050.74
CRBU
CARIBOU BIOSCIENCES INC
$1.111,163,00031.12%1.141.100.931.061.5153.3352.4562.4136.4853.250.070.07-0.001.79
QSI
QUANTUM-SI INC
$1.668,176,000-11.93%1.711.701.421.531.4352.0230.1834.5825.3127.490.080.10-0.021.89
ADTX
ADITXT INC
$1.3880,000-9.09%1.471.592.129.76577.1932.1820.2725.9872.0780.54-0.34-0.440.100.56
CMPX
COMPASS THERAPEUTICS INC
$2.41747,00068.24%2.372.231.982.392.0364.0953.7660.0636.7253.110.130.110.020.97
CDIO
CARDIO DIAGNOSTICS HOLDINGS INC
$4.0662,000-31.87%4.454.348.1211.0612.3236.5821.2834.4453.4765.89-1.06-1.310.250.87
ORIC
ORIC PHARMACEUTICALS INC
$9.63714,000-12.39%9.277.726.137.328.3773.1988.8889.9874.1980.841.100.930.171.09
GHRS
GH RESEARCH PLC
$12.76147,000-68.52%12.7112.2410.7311.259.7356.0369.6275.3735.0449.660.640.600.040.95
CAPR
CAPRICOR THERAPEUTICS INC
$11.783,117,000196.29%12.7211.5710.6512.1813.2451.1262.5870.0246.5061.350.820.620.190.99
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$0.73773,00048.08%0.810.900.821.141.2839.082.497.260.004.82-0.03-0.01-0.020.62
SXTP
60 DEGREES PHARMACEUTICALS INC
$2.2194,50062.93%2.702.542.582.544.1840.9118.7331.1712.9838.140.010.05-0.04-0.46
LTRN
LANTERN PHARMA INC
$3.05128,000-34.69%3.293.263.423.813.6940.5054.4466.3663.7979.37-0.08-0.080.001.13
MGTX
MEIRAGTX HOLDINGS PLC
$6.63487,0000.21%6.085.635.776.305.8962.5177.7483.0477.1984.150.220.040.181.19
ALT
ALTIMMUNE INC
$6.924,336,000-34.76%6.065.835.315.726.5566.8477.9481.5287.0291.310.340.190.151.29
SION
SIONNA THERAPEUTICS INC
$16.38101,000-3.81%16.2914.8812.80N/AN/A58.5269.0978.3158.5072.101.160.950.210.93
OCGN
OCUGEN INC
$1.134,867,0003.27%1.030.940.790.730.8470.4582.5880.4785.6895.230.110.080.031.90
AUTL
AUTOLUS THERAPEUTICS PLC
$2.121,897,000-32.56%2.191.871.551.742.5664.5272.1679.7942.2464.570.210.190.021.01
ABSI
ABSCI CORP
$2.782,238,000-19.03%2.892.812.853.323.4445.8742.9855.4853.1272.570.01-0.010.012.11
MBX
MBX BIOSCIENCES INC
$10.37123,000-12.77%11.8512.0710.229.96N/A40.311.275.770.000.820.080.45-0.371.45
RPTX
REPARE THERAPEUTICS INC
$1.4737,200-51.69%1.451.401.291.232.0361.1670.5173.5646.4657.980.040.04-0.001.17
BLTE
BELITE BIO INC
$59.5521,000-36.94%62.4463.2661.0861.1160.8842.3319.6719.0824.7125.40-0.330.19-0.520.16
GALT
GALECTIN THERAPEUTICS INC
$1.37188,00088.00%1.321.301.331.391.8555.6072.5568.1992.0492.09-0.00-0.010.010.78
CRIS
CURIS INC
$2.4570,000-26.32%2.482.291.932.433.4555.7260.9371.8469.9985.840.160.130.030.89
TIL
INSTIL BIO INC
$34.23221,000-3.49%33.8127.8119.8520.2226.3362.6969.6475.6943.9463.955.164.560.611.75
URGN
UROGEN PHARMA LTD
$12.0319,687,000-6.61%7.186.168.689.6910.9171.8980.8278.5199.5697.120.19-0.710.900.91
BCLI
BRAINSTORM CELL THERAPEUTICS INC
$1.10262,00011.49%1.171.171.101.381.8944.4652.5366.0952.5977.580.010.000.000.73
ZVSA
ZYVERSA THERAPEUTICS INC
$0.65380,000-66.19%0.670.620.650.861.3151.5063.5465.7877.6089.900.020.000.010.23
MRNA
MODERNA INC
$26.677,146,000-13.80%27.3326.8826.2730.3041.3348.8747.6655.7046.6065.480.230.150.081.20
INO
INOVIO PHARMACEUTICALS INC
$2.00617,000-15.83%2.152.091.901.953.2947.4432.4751.131.9426.690.060.07-0.011.43
SAGE
SAGE THERAPEUTICS INC
$6.70647,00053.68%6.726.716.977.256.8947.2639.5351.0649.3366.09-0.07-0.110.041.11
AARD
AARDVARK THERAPEUTICS INC
$10.7414,8003.50%11.4810.939.81N/AN/A49.3751.1664.3428.1151.050.350.41-0.051.23
PRTG
PORTAGE BIOTECH INC
$5.9917,700-61.85%7.577.828.086.415.8133.914.378.970.003.97-0.36-0.13-0.231.09
GLSI
GREENWICH LIFESCIENCES INC
$9.2023,000164.37%9.509.709.6310.7612.1440.7221.0327.4231.9544.57-0.11-0.08-0.030.55
KRRO
KORRO BIO INC
$13.5466,500-8.90%13.4613.6714.7120.8734.0146.5758.4567.9568.1881.35-0.38-0.690.301.15
EYPT
EYEPOINT PHARMACEUTICALS INC
$9.03822,0003.92%8.587.446.516.597.7872.6484.0086.2278.2185.270.770.610.161.11
CVM
CEL SCI CORP
$2.25152,00031.03%2.413.055.758.0416.1124.9948.3339.7790.4391.34-1.11-1.240.120.90
ATOS
ATOSSA THERAPEUTICS INC
$0.83518,000-27.96%0.870.870.790.791.0447.3062.4267.0153.8966.480.010.02-0.011.30
PMVP
PMV PHARMACEUTICALS INC
$1.08177,000-31.66%1.020.960.961.141.3561.3766.6777.6663.1377.460.040.010.031.20
MTSR
METSERA INC
$29.38808,00067.98%30.4729.3324.24N/AN/A52.1954.8962.5844.8568.691.891.690.211.81
RAPP
RAPPORT THERAPEUTICS INC
$11.19101,000-46.84%12.0010.9310.4911.4016.1450.7353.1161.7858.3472.050.450.380.071.27
VIR
VIR BIOTECHNOLOGY INC
$5.22893,00012.05%5.274.995.366.977.5349.6566.2872.7274.4183.09-0.02-0.100.071.18
VERU
VERU INC
$0.611,781,000-28.27%0.630.570.550.560.6655.8163.3876.3363.6476.620.030.030.011.03
DOMH
DOMINARI HOLDINGS INC
$4.86111,00025.42%5.004.974.755.183.4047.4969.6877.5166.3080.110.040.010.031.09
CNSP
CNS PHARMACEUTICALS INC
$0.81337,00019.93%0.981.071.082.344.2930.047.039.620.005.35-0.09-0.08-0.010.72
PDSB
PDS BIOTECHNOLOGY CORP
$1.75332,000-53.70%1.651.571.331.361.9964.2474.0776.7793.0289.190.110.090.021.90
ELTX
ELICIO THERAPEUTICS INC
$7.6034,30035.04%7.887.025.936.995.9658.6767.5171.5046.8165.550.600.570.031.05
ACRV
ACRIVON THERAPEUTICS INC
$1.20308,0002.67%1.241.191.393.255.2941.7754.6359.8870.7376.45-0.08-0.130.051.47
SCPH
SCPHARMACEUTICALS INC
$3.95211,000-3.21%4.073.762.973.073.5862.4766.6775.5620.8051.900.340.35-0.010.98
PRTA
PROTHENA CORP PUBLIC LTD CO
$5.08806,00023.62%5.065.547.6410.9213.8431.7442.0034.7282.5985.81-0.80-0.960.161.42
INAB
IN8BIO INC
$2.26173,000-29.10%3.233.684.405.987.6426.551.452.630.005.58-0.57-0.42-0.150.95
SLNO
SOLENO THERAPEUTICS INC
$79.15621,000-36.57%77.6976.3873.6261.9656.2659.9681.7187.3285.7289.781.751.590.160.54
COYA
COYA THERAPEUTICS INC
$5.6367,000-62.98%5.675.685.796.126.3247.1638.0144.3642.0649.76-0.09-0.090.000.90
MRUS
MERUS NV
$54.61712,000-52.41%56.7252.3146.0145.0546.3456.4048.9658.0713.9729.253.103.33-0.230.95
ELDN
ELEDON PHARMACEUTICALS INC
$2.87195,00062.50%3.023.043.043.553.6041.2217.4821.5710.4311.81-0.04-0.03-0.010.71
EWTX
EDGEWISE THERAPEUTICS INC
$15.29878,000-13.41%15.1314.7814.3620.1024.3452.2868.6875.9482.6991.810.03-0.140.181.39
FBRX
FORTE BIOSCIENCES INC
$12.0934,400616.67%11.159.787.838.9110.2466.9077.1877.7669.4973.131.321.040.280.80
NUVB
NUVATION BIO INC
$1.738,955,000-52.13%2.302.262.132.142.4032.6511.8838.300.0033.33-0.020.05-0.071.16
GLPG
GALAPAGOS NV
$28.76322,000120.55%28.4528.5826.6825.8926.9459.5956.9045.7543.8835.430.460.56-0.100.62
TRML
TOURMALINE BIO INC
$19.68152,000-47.95%18.9017.4216.1215.6219.4169.2488.2884.1992.1889.701.010.760.251.23
IGMS
IGM BIOSCIENCES INC
$1.21148,00030.97%1.271.251.231.306.2846.0819.1339.2210.3639.780.000.01-0.001.62
ALLO
ALLOGENE THERAPEUTICS INC
$1.342,450,0007.31%1.371.241.341.592.0351.8976.6382.6479.0189.740.03-0.010.031.39
NAUT
NAUTILUS BIOTECHNOLOGY INC
$0.70161,000-21.46%0.740.760.751.071.7441.9210.3321.481.5618.46-0.02-0.01-0.011.52
OABI
OMNIAB INC
$1.78870,0003.57%1.521.461.652.423.2064.7291.6987.80100.00100.00-0.01-0.070.070.54
RNXT
RENOVORX INC
$1.30139,00088.86%1.371.311.101.101.1255.3159.6764.747.488.740.070.08-0.010.87
MBRX
MOLECULIN BIOTECH INC
$0.64307,000-38.23%0.710.820.901.061.7130.0414.7815.6216.2113.82-0.09-0.07-0.020.85
APGE
APOGEE THERAPEUTICS INC
$44.481,255,00014.09%39.9539.4037.1837.3643.8567.2085.3683.1595.8995.101.230.650.581.25
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
$44.21316,000-61.46%46.1642.4739.9740.8845.5754.8742.0646.7125.2332.341.701.650.040.58
IPA
IMMUNOPRECISE ANTIBODIES LTD
$0.703,690,000-94.64%0.640.580.500.460.4965.8040.9250.7229.4533.240.060.050.010.78
RLMD
RELMADA THERAPEUTICS INC
$0.70201,000-72.24%0.760.690.500.401.3755.9845.0959.910.0023.440.080.09-0.010.68
VTYX
VENTYX BIOSCIENCES INC
$2.56844,000-46.34%2.342.001.491.541.8972.5276.9781.5649.0164.630.320.260.051.38
VTGN
VISTAGEN THERAPEUTICS INC
$2.21160,00050.94%2.352.432.302.532.7338.8217.5724.823.579.15-0.020.01-0.031.65
QNCX
QUINCE THERAPEUTICS INC
$1.43656,000-54.03%1.181.101.081.271.3172.8288.4089.5388.6790.710.060.020.040.69
AVTX
AVALO THERAPEUTICS INC
$4.8444,200-5.96%4.534.194.566.107.9758.6187.8987.1595.7396.520.05-0.100.150.85
CRGX
CARGO THERAPEUTICS INC
$4.39396,000-0.25%4.524.334.304.6611.3651.3957.8167.3032.3847.190.080.070.021.04
DBVT
DBV TECHNOLOGIES SA
$9.1013,600-67.39%8.679.038.866.725.1751.3968.0361.4881.2082.170.01-0.000.010.53
HOWL
WEREWOLF THERAPEUTICS INC
$1.22307,000-40.62%1.301.231.001.131.5652.2136.8449.266.3015.460.080.09-0.011.40
MDCX
MEDICUS PHARMA LTD
$2.60133,000-26.92%2.734.404.273.76N/A35.316.217.2411.3410.39-0.64-0.45-0.190.63

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)


Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #1 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 62, which is 38 points higher than the biotech industry average of 24.

AUPH passed 20 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 52.9% over the past year, overperforming other biotech stocks by 129 percentage points.

2. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 67, which is 43 points higher than the biotech industry average of 24.

EXEL passed 22 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 89.39% over the past year, overperforming other biotech stocks by 166 percentage points.

Exelixis has an average 1 year price target of $39.94, a downside of -3.97% from Exelixis's current stock price of $41.59.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Exelixis, 31.25% have issued a Strong Buy rating, 18.75% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)


Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 73, which is 49 points higher than the biotech industry average of 24.

CPRX passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 53.49% over the past year, overperforming other biotech stocks by 130 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.50, an upside of 38.12% from Catalyst Pharmaceuticals's current stock price of $23.53.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Catalyst Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.58%, which is 5 percentage points higher than the biotech industry average of 1.63%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.02%, which is the same as the biotech industry average of 1.63%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.87%, which is the same as the biotech industry average of 1.63%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.4% in the last day, and down -1.07% over the last week. Biorestorative Therapies was the among the top losers in the biotechnology industry, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the biotech industry by 77 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the biotech industry by 87 percentage points.

3. United Therapeutics (NASDAQ:UTHR)


United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -1.47% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

53.31% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 99.94% over the next year.

2.39% of biotech stocks have a Zen Rating of A (Strong Buy), 4.56% of biotech stocks are rated B (Buy), 35.57% are rated C (Hold), 36.66% are rated D (Sell), and 20.82% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -108.97x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.